Literature DB >> 19515412

PPAR-alpha and PPAR-gamma agonists for type 2 diabetes.

Bernard Charbonnel1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19515412     DOI: 10.1016/S0140-6736(09)61040-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty.

Authors:  Janice V Huang; Clifford R Greyson; Gregory G Schwartz
Journal:  J Lipid Res       Date:  2012-06-08       Impact factor: 5.922

2.  The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.

Authors:  C M Werner; S H Schirmer; C Gensch; V Pavlickova; J Pöss; M B Wright; M Böhm; U Laufs
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

3.  Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells.

Authors:  Ling Chen; Long Li; Junde Chen; Lei Li; Zihan Zheng; Jie Ren; Yan Qiu
Journal:  Oncotarget       Date:  2015-12-15

4.  Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver.

Authors:  Patricia Rivera; Antoni Pastor; Sergio Arrabal; Juan Decara; Antonio Vargas; Laura Sánchez-Marín; Francisco J Pavón; Antonia Serrano; Dolores Bautista; Anna Boronat; Rafael de la Torre; Elena Baixeras; M Isabel Lucena; Fernando R de Fonseca; Juan Suárez
Journal:  Front Pharmacol       Date:  2017-10-06       Impact factor: 5.810

5.  Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.

Authors:  Mukul R Jain; Suresh R Giri; Bibhuti Bhoi; Chitrang Trivedi; Akshyaya Rath; Rohan Rathod; Ramchandra Ranvir; Shekhar Kadam; Hiren Patel; Prabodha Swain; Sib Sankar Roy; Nabanita Das; Eshani Karmakar; Walter Wahli; Pankaj R Patel
Journal:  Liver Int       Date:  2017-12-14       Impact factor: 5.828

Review 6.  In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes.

Authors:  Jirawat Riyaphan; Dinh-Chuong Pham; Max K Leong; Ching-Feng Weng
Journal:  Biomolecules       Date:  2021-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.